Stills Disease Treatment Market, By Treatment, By Route of Administration, By Distribution Channels and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Description
Still's disease, also known as Adult-onset Still's Disease (AOSD), is a rare inflammatory disease characterized by joint pain, rash, and fever. This devastating condition can lead to long-term chronic arthritis and permanent injuries. Still's disease is associated with a rash that does not itch and a high fever. This disorder can destroy the affected joints, especially the wrists. Treatment for Still's disease includes anti-inflammatory medications. Still's disease is a rare rheumatic disease. This disease is characterized by biological and clinical symptoms such as high fever, joint swelling, myalgia, sore throat, increase in white blood cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for Still's disease can be divided into two categories, namely symptomatic treatments and effective treatments. Symptomatic treatment can be started immediately even if the diagnosis is not confirmed, while effective treatment methods are designed to treat the disease more effectively to eliminate the symptoms of the disease.
Market Dynamics
Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global Still’s disease treatment market growth. For instance, on April 13, 2023, Metropolis Healthcare noted that treatment of Still's disease with nonsteroidal anti-inflammatory drugs (NSAIDs), these medications reduce inflammatory pain and the signs and symptoms of Still’s disease. Corticosteroids reduce inflammation by reducing the activity of the immune system. Disease-modifying Antirheumatic Drugs (DMARDs) can help slow down the progress of Still’s disease and reduce the frequency of flares. Physical therapy, exercise, rest, and a healthy diet can help manage the condition and keep symptoms to a minimum.
Key features of the study:
Market Dynamics
Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global Still’s disease treatment market growth. For instance, on April 13, 2023, Metropolis Healthcare noted that treatment of Still's disease with nonsteroidal anti-inflammatory drugs (NSAIDs), these medications reduce inflammatory pain and the signs and symptoms of Still’s disease. Corticosteroids reduce inflammation by reducing the activity of the immune system. Disease-modifying Antirheumatic Drugs (DMARDs) can help slow down the progress of Still’s disease and reduce the frequency of flares. Physical therapy, exercise, rest, and a healthy diet can help manage the condition and keep symptoms to a minimum.
Key features of the study:
- This report provides an in-depth analysis of the global Still’s disease treatment market and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Still’s disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include AB2 Bio Ltd , F.offmann-La Roche Ltd, Novartis AG, Swedish Orphan Biovitrum AB, Jubilant Life Sciences Ltd, Vintage Labs, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Mylan N.V, Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Amneal Pharmaceuticals LLC, Dr Reddy's Laboratories Ltd, and Fresenius Kabi AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Still’s disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Still’s disease treatment market
- Global Still’s Disease Treatment Market, By Treatment :
- Pain Management
- Corticosteroids
- Tocilizumab
- Canakinumab
- Others
- Global Still’s Disease Treatment Market, By Route of Administration :
- Injectables
- Oral
- Global Still’s Disease Treatment Market, By Distribution Channels :
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Global Still’s Disease Treatment Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- AB2 Bio Ltd.
- F.Hoffmann-La Roche Ltd
- Novartis AG
- Swedish Orphan Biovitrum AB
- Jubilant Life Sciences Ltd
- Vintage Labs
- Hikma Pharmaceuticals PLC
- Teva Pharmaceutical Industries Ltd
- Mylan N.V
- Horizon Therapeutics plc
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Amneal Pharmaceuticals LLC
- Dr Reddy's Laboratories Ltd
- Fresenius Kabi AG
Table of Contents
255 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- 4. Global Still’s Disease Treatment Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Still’s Disease Treatment Market, By Treatment, 2020–2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis,
- Segment Trends
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Tocilizumab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Canakinumab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- 6. Global Still’s Disease Treatment Market, By Route of Administration, 2020–2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- 7. Global Still’s Disease Treatment Market, By Distribution Channel, 2020–2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Online Pharmacies
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- 8. Global Still’s Disease Treatment Market, By Region, 2020–2032, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021–2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020–2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- AB2 Bio Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F.Hoffmann-La Roche Ltd
- Novartis AG
- Swedish Orphan Biovitrum AB
- Jubilant Life Sciences Ltd
- Vintage Labs
- Hikma Pharmaceuticals PLC
- Teva Pharmaceutical Industries Ltd
- Mylan N.V
- Horizon Therapeutics plc
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Amneal Pharmaceuticals LLC
- Dr Reddy's Laboratories Ltd
- Fresenius Kabi AG
- 10. Section
- Research Methodology
- About Us
- *Browse 40 market data tables and 48 figures on “Global Still’s Disease Treatment Market”- Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
